Lung Cancer Stocks List

Lung Cancer Stocks Recent News

Date Stock Title
May 15 BIAF bioAffinity Technologies Reports Record Q1 Revenue Driven by Accelerating Growth of CyPath® Lung Sales and Increased Laboratory Volumes
May 14 OCX OncoCyte Q1 2024 Earnings Preview
May 14 CRIS Curis Announces Additional Data from TakeAim Leukemia Study
May 14 ICCM Here's Why It's Unlikely That IceCure Medical Ltd's (NASDAQ:ICCM) CEO Will See A Pay Rise This Year
May 14 BNR Burning Rock Announces ADS Ratio Change to Be Effective on May 15, 2024
May 13 CNTA Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the First Quarter of 2024
May 13 OCX OncoCyte files to sell 5.42M shares of common stock for holders
May 13 VCYT Wall Street Analysts Believe Veracyte (VCYT) Could Rally 39.59%: Here's is How to Trade
May 13 OCX Oncocyte to Announce First Quarter 2024 Financial Results
May 12 SNDX Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Q1 2024 Earnings Call Transcript
May 11 BDSX Biodesix, Inc. (NASDAQ:BDSX) Just Reported Earnings, And Analysts Cut Their Target Price
May 10 BDSX Biodesix, Inc. (NASDAQ:BDSX) Q1 2024 Earnings Call Transcript
May 10 BDSX Biodesix Inc (BDSX) Surpasses Analyst Revenue Forecasts with Strong Q1 2024 Performance
May 10 CRIS Curis to Present Updated Data from the TakeAim Leukemia Study
May 10 BDSX Biodesix First Quarter 2024 Earnings: Beats Expectations
May 10 BDSX Biodesix, Inc. (BDSX) Q1 2024 Earnings Call Transcript
May 9 SNDX Syndax Announces Participation at the Bank of America Securities 2024 Health Care Conference
May 9 VCYT Is Veracyte, Inc. (NASDAQ:VCYT) Trading At A 43% Discount?
May 9 BDSX Biodesix Inc (BDSX) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and ...
May 9 SNDX Syndax Pharmaceuticals Inc (SNDX) Q1 2024 Earnings Call Transcript Highlights: Strategic ...
Lung Cancer

Lung cancer, also known as lung carcinoma, is a malignant lung tumor characterized by uncontrolled cell growth in tissues of the lung. This growth can spread beyond the lung by the process of metastasis into nearby tissue or other parts of the body. Most cancers that start in the lung, known as primary lung cancers, are carcinomas. The two main types are small-cell lung carcinoma (SCLC) and non-small-cell lung carcinoma (NSCLC). The most common symptoms are coughing (including coughing up blood), weight loss, shortness of breath, and chest pains.The vast majority (85%) of cases of lung cancer are due to long-term tobacco smoking. About 10–15% of cases occur in people who have never smoked. These cases are often caused by a combination of genetic factors and exposure to radon gas, asbestos, second-hand smoke, or other forms of air pollution. Lung cancer may be seen on chest radiographs and computed tomography (CT) scans. The diagnosis is confirmed by biopsy which is usually performed by bronchoscopy or CT-guidance.Avoidance of risk factors, including smoking and air pollution, is the primary method of prevention. Treatment and long-term outcomes depend on the type of cancer, the stage (degree of spread), and the person's overall health. Most cases are not curable. Common treatments include surgery, chemotherapy, and radiotherapy. NSCLC is sometimes treated with surgery, whereas SCLC usually responds better to chemotherapy and radiotherapy.Worldwide in 2012, lung cancer occurred in 1.8 million people and resulted in 1.6 million deaths. This makes it the most common cause of cancer-related death in men and second most common in women after breast cancer. The most common age at diagnosis is 70 years. Overall, 17.4% of people in the United States diagnosed with lung cancer survive five years after the diagnosis, while outcomes on average are worse in the developing world.

Browse All Tags